How Can We Help You?

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Lung Cancer Trials

Select Clinical Trial

Protocol Number: CALGB 30610

Protocol Title: Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide

Eligibility: Men or women, ages 18 and older, diagnosed with limited-stage small-cell lung cancer. 

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: EA5161

Protocol Title:  Randomized Phase II Clinical Trial of Cisplatin/Carboplatin and Etoposide (CE) alone or in Combination with Nivolumab as Frontline Therapy for Extensive Stage Small Cell Lung Cancer (ED-SCLC)

Eligibility: Men or women, ages 18 and older, diagnosed with extensive stage/advanced small cell lung cancer

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: ALCHEMIST

Protocol Title: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial

Eligibility: Men or women, ages 18 or older, diagnosed with Stage IIIA, II or large IB non-small cell lung cancer (NSCLC). 

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: Neuwave NEU_2017_06

Protocol Title: A Multicenter Study of the NEUWAVE Fex Microwave Ablation System in the Ablation of Medically Inoperable Primary Soft Tissue Lesions of the Lung: An Initial Experience

Eligibility: Men or women, ages 18 and older, lung cancer nodule not appropriate for surgery or elect not to have surgery

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: GSK FSP 205801

Protocol Title: A Phase II, Randomized, Open-label Master Protocol to Study Novel Regimens Versus Standard of Care Treatment in NSCLC Participants

Eligibility: Men or women, ages 18 and older, diagnosed with non-small cell lung cancer, stage IIB or IV, which has progressed following treatment.

Contact Information: (910) 715-2200

____________________________________________________________________________________________

Protocol Number: LUNGMAP

Protocol Title: Master Protocol to evaluate biomarker-driven therapies and immunotherapies in previously-treated non-small cell lung cancer (Lung-MAP Screening Study)

Eligibility: Men or women, ages 18 and older, diagnosed with non-small cell lung cancer, DISEASE MUST BE EITHER ADVANCED, stage IIIB or IV or recurrent.

Contact Information: (910) 715-2200

____________________________________________________________________________________________

 

Specialties
Clara McLean House
Make a Donation
News & Events